We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Four Point Test Flags Patients at Risk of Dying from Clostridium difficile Infection

By LabMedica International staff writers
Posted on 20 Aug 2013
Analysis of metabolic and mortality data from a group of patients with Clostridium difficile infections has allowed the establishment of a prediction rule based on clinical variables to aid hospital physicians to rank incoming patients according to risk of dying from the infection.

C. More...
difficile is an anaerobic, spore forming, rod shaped bacterium, and is a prevalent cause of nosocomial infection. Furthermore, antibiotic resistant strains of C. difficile are a growing problem in healthcare systems. Recent C. difficile epidemics have been caused by hypervirulent strains, which became resistant to the fluoroquinolones soon after their introduction into the healthcare setting.

When C. difficile bacteria are introduced into a colon in which the normal gut flora has been destroyed (usually after a broad-spectrum antibiotic such as clindamycin has been used), the gut becomes overrun with C. difficile. This overpopulation is harmful because the bacteria release toxins that can cause bloating and diarrhea, with abdominal pain, which may become severe. C. difficile infections are the most common cause of pseudomembranous colitis, and in rare cases, this can progress to toxic megacolon, which can be life threatening.

Investigators at the University of Exeter (United Kingdom) and the Royal Devon & Exeter Hospital (United Kingdom) evaluated over 186 variables collated retrospectively from clinical data for 213 patients. From this data, they devised a simple four variable prediction rule that included serum albumin levels, respiratory rate, C-reactive protein, and white cell count. Threshold levels of these variables were associated with an increased risk of all-cause mortality.

Contributing author Dr. Steve Michell, senior lecturer in molecular microbiology at the University of Exeter, said, "Our findings are exciting because they identify a simple, accurate, and robust method to identify those patients who are at risk of dying from a C difficile infection. The clinical variables identified are easily measurable, using tests that are commonly carried out in hospital. The results of our study strengthen the evidence for establishing the use of this rule in clinical settings: the benefits to patient well-being, the efficient management of infection in hospital and potential savings to the NHS and other health services around the world, would be immense."

The study was published in the July 12, 2013, online edition of the journal BMC Infectious Diseases.

Related Links:
University of Exeter
Royal Devon & Exeter Hospital


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Gold Member
Pipette Management Software
VIALINK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.